SePaCS--a web-based application for classification of seroreactivity profiles.

Area of Science:

• Biomarker Discovery
• Computational Biology
• Clinical Diagnostics

Background:

• Immunogenic antigen sets are crucial for minimally invasive disease detection and monitoring.
• Blood sera of patients with diseases like cancer contain specific antigen sets.
• Statistical learning is typically used to classify patient sera based on antigen profiles.

Purpose of the Study:

• To develop a user-friendly web application for analyzing seroreactivity profiles.
• To enable clinical groups to perform training set analyses and predictions with minimal effort.
• To provide a platform for classifying sera as tumor or normal.

Main Methods:

• Development of the Seroreactivity Profile Classification Service (SePaCS) web application.
• Implementation of multiple classification methods: Naïve Bayes Classifier (four versions), Support Vector Machines (SVM) with radial basis function kernel, Linear Discriminant Analysis (LDA), and Diagonal Discriminant Analysis (DDА).
• Demonstration of SePaCS functionality using meningioma and glioma patient sera data.

Main Results:

• SePaCS successfully enables classification of seroreactivity profiles.
• The application was validated using data from meningioma (benign brain tumor) and glioma (malignant brain tumor) cases.
• Computed results are conveniently summarized in a PDF file.

Conclusions:

• SePaCS offers a valuable tool for clinical research in disease detection and monitoring.
• The web application simplifies the analysis of seroreactivity data for disease classification.
• SePaCS supports the advancement of minimally invasive diagnostic strategies through immunogenic antigen profiling.